305 The Spectrum of Adjuvant Therapy for Brain Tumors

Wednesday, April 17
7:00 am - 9:00 am
Location: 32AB; SDCC

Fee: $150
Advanced Practice Provider Fee: $150
Candidate and Medical Student Fee: $65

Moderator(s): Randy Lynn Jensen, MD, PhD, FAANS

Panelist(s): Ichiro Nakano, MD, PhD, MSc; Colin Watts, PhD (United Kingdom)

This seminar will provide a state-of-the-art review of the different adjuvant treatment options available for patients with malignant brain tumors. It will review current standards of care and then explore newer treatment options, including targeted therapies, intratumoral strategies, immunotherapeutic approaches and viral therapies.

Learning Objectives: After completing this educational activity, participants should be able to:

  • Describe current standards of care for adjuvant therapy of malignant gliomas, as well as current scientific advances and newly developed adjuvant therapies for them.
  • Discuss current problems with the design of effective therapies and recommend appropriate treatment options for patients with brain tumors.
  • Design the best treatment programs, based on current data.